Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...

CompanyOverview\|NASDAQ:MRNA] The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market.

Moderna stock is under pressure, again, as Robert F. Kennedy Jr. reportedly mulls pulling the company's federal funding to ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Despite high R&D spending and cash burn, Moderna aims for breakeven by 2028, driven by new vaccine opportunities. Explore ...

Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals announced an ...

Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals JAZZ announced an agreement to acquire Chimerix CMRX. Meanwhile, other pi ...

Moderna shares experienced a significant surge in trading on Thursday, posting a 5.58% gain in European markets and an impressive jump of up to 16% on the NASDAQ. This remarkable performance was ...

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open ...

Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals JAZZ announced an agreement to acquire Chimerix CMRX. Meanwhile, other pipeline and regulatory ...

Moderna’s CEO Stephane Bancel and director Paul Sagan acquired common stock worth $6 million. MRNA also secured a legal victory in a patent dispute against Pfizer and BioNTech. A German court ...

A few days ago, Moderna's CEO Stephane Bancel reportedly made two large purchases of Moderna stock, which is usually interpreted as a good sign. Bancel also sold stock during the pandemic when ...